Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Caribou Biosciences Inc (NASDAQ: CRBU) closed at $2.73 in the last session, up 28.17% from day before closing price of $2.13. In other words, the price has increased by $28.17 from its previous closing price. On the day, 10.12 million shares were traded. CRBU stock price reached its highest trading level at $2.745 during the session, while it also had its lowest trading level at $2.08.
Ratios:
We take a closer look at CRBU’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.49 and its Current Ratio is at 10.49. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on June 03, 2024, Downgraded its rating to In-line and sets its target price to $3 from $13 previously.
On October 31, 2023, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $13.Evercore ISI initiated its Outperform rating on October 31, 2023, with a $13 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRBU now has a Market Capitalization of 246567600 and an Enterprise Value of -20261486. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.38 while its Price-to-Book (P/B) ratio in mrq is 0.72. Its current Enterprise Value per Revenue stands at -0.607 whereas that against EBITDA is 0.159.
Stock Price History:
The Beta on a monthly basis for CRBU is 2.35, which has changed by -0.59314454 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, CRBU has reached a high of $8.33, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is 10.78%, while the 200-Day Moving Average is calculated to be -40.68%.
Shares Statistics:
According to the various share statistics, CRBU traded on average about 2.40M shares per day over the past 3-months and 2745860 shares per day over the past 10 days. A total of 88.45M shares are outstanding, with a floating share count of 79.88M. Insiders hold about 11.55% of the company’s shares, while institutions hold 74.64% stake in the company. Shares short for CRBU as of 1719532800 were 10245703 with a Short Ratio of 4.27, compared to 1717113600 on 11510278. Therefore, it implies a Short% of Shares Outstanding of 10245703 and a Short% of Float of 11.89.
